Alerts will be sent to your verified email
Verify Email
MOREPENLAB
|
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.43 % | 8.9 % | -8.31 % |
|
5yr Avg Net Profit Margin
|
5.93 % | 6.28 % | -5.56 % |
|
Price to Book
|
2.28 | 1.62 | 2.79 |
|
P/E
|
28.5 | 26.03 | 124.6 |
|
5yr Avg Cash Conversion Cycle
|
12.78 Days | 37.81 Days | 115.03 Days |
|
5yr Average Interest Coverage Ratio
|
39.11 | 15.8 | 0.55 |
|
5yr Avg ROCE
|
15.77 % | 12.63 % | 3.01 % |
|
5yr Avg Operating Profit Margin
|
8.68 % | 10.64 % | 10.34 % |
|
5 yr average Debt to Equity
|
0.04 | 0.04 | 0.69 |
|
5yr CAGR Net Profit
|
3.98 % | -9.63 % | n/a |
|
5yr Average Return on Assets
|
7.67 % | 6.27 % | -2.61 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
35.65 % | 52.62 % | 42.01 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 38.95 % |
|
Change in Promoter Holding (3 Yrs)
|
-1.09 % | 8.93 % | 1.61 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -1.56 % |
|
Morepen Laboratories
|
IOL Chem & Pharma
|
Solara Active Pharma
|
|---|